Sign in
8-K

Current Report

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-419829

Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 3.02 Unregistered sales of equity securities
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading tcrt-20261013.htm…